Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Smith, Antony
DOB: 19-APR-1946 (Age: 79)
Gender: male
ID: 1069-793368-6 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 22-JUL-2025

Problem list

Condition Onset Date Status
Chronic kidney disease stage 3 08-Dec-2020 active
Chronic kidney disease stage 2 26-Jul-2016 active
Alzheimer's disease 10-Mar-2015 active
Chronic kidney disease stage 1 11-Mar-2014 active
Ischemic heart disease 19-Mar-2013 active
Proteinuria due to type 2 diabetes mellitus 24-Feb-2009 active
Hyperlipidemia 01-Feb-2005 active
Impacted molars 16-Aug-2004 active
Chronic sinusitis 29-Jan-2003 active
Microalbuminuria due to type 2 diabetes mellitus 12-Dec-1995 active
Disorder of kidney due to diabetes mellitus 30-Nov-1993 active
Metabolic syndrome X 21-Oct-1986 active
Essential hypertension 28-Sep-1983 active
Anemia 16-Jul-1974 active
Prediabetes 07-Dec-1971 active

Medication list

No known medications

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 15-Apr-2025
Clostridium tetani toxoid antigen adsorbed only vaccine product 01-Oct-2024
SARS-CoV-2 mRNA vaccine 16-Mar-2021

Procedure History list

Procedure Date Reason
Depression screening 15-Jul-2025 -
Assessment of health and social care needs 15-Jul-2025 -
Assessment using Morse Fall Scale 15-Jul-2025 -
Screening for domestic abuse 15-Jul-2025 -
Depression screening using Patient Health Questionnaire Two-Item score (procedure) 15-Jul-2025 -
Medication reconciliation 10-Jun-2025 -
Assessment of anxiety 10-Jun-2025 -
Screening for drug abuse 13-May-2025 -
Depression screening using PHQ-9 (Patient Health Questionnaire 9) score 13-May-2025 -
Assessment of substance use 13-May-2025 -
Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) 11-Mar-2025 -
Patient discharge 14-Oct-2018 -
Hospice care 13-Oct-2018 -
Notifications 02-Oct-2018 -
Certification procedure 02-Oct-2018 -
Initial patient assessment 02-Oct-2018 -
Development of individualized plan of care 02-Oct-2018 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Dementia management 10-Mar-2015 Alzheimer's disease (disorder)
  • Maintain or slow decline in cognitive function as measured by MMSE.
  • Ensure patient or caregiver administers prescribed dementia medications as directed.
  • Minimize frequency and severity of behavioral disturbances such as agitation or aggression.
  • Maintain independence in basic activities of daily living for as long as possible.
  • Provide caregiver with education and resources to support dementia care at home.
Care plan 14-May-2013 -
Dialysis care plan 20-May-2008 -
Hyperlipidemia clinical management plan 22-Feb-2005 Hyperlipidemia
  • Achieve and maintain LDL cholesterol below 1.8 mmol/L to reduce cardiovascular risk.
  • Achieve and maintain total cholesterol below 4.0 mmol/L.
  • Achieve and maintain triglycerides below 1.7 mmol/L.
  • Maintain HDL cholesterol above 1.0 mmol/L.
Lifestyle education regarding hypertension 28-Sep-1983 Essential hypertension (disorder)
  • Patient will achieve and maintain target blood pressure to reduce cardiovascular and renal risk.
  • Patient will implement recommended lifestyle changes (diet, exercise, sodium reduction, weight management) to support blood pressure control.
Diabetes self management plan 07-Dec-1971 Prediabetes
  • Patient will implement and maintain a diabetes self-management plan including dietary changes, physical activity, and regular blood glucose monitoring to prevent progression to type 2 diabetes.
  • Patient will maintain hemoglobin A1c below the diagnostic threshold for diabetes.
Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 01-Oct-2025 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-07-15 2025-06-10
Body Height 171.6 cm 171.6 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} 3 {score}
Body Weight 81.1 kg 81.1 kg
Body mass index (BMI) [Ratio] 27.5 kg/m2 27.5 kg/m2
Diastolic Blood Pressure 86 mm[Hg] 89 mm[Hg]
Systolic Blood Pressure 116 mm[Hg] 121 mm[Hg]
Heart rate 61 /min 86 /min
Respiratory rate 12 /min 14 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 22-JUL-2025 Reference Range Unit
Glucose [Mass/volume] in Serum or Plasma 64.7 L 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 9.4 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 1.9 H 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Serum or Plasma 9.7 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Serum or Plasma 138.7 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 5.2 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Serum or Plasma 101.4 98 - 111 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 24.1 22 - 32 mmol/L
Appearance of Urine Cloudy urine
Odor of Urine Urine smell ammoniacal
Clarity of Urine Translucent
Color of Urine Brown color
Glucose [Mass/volume] in Urine by Test strip 0.8 0 - 0.8 mg/dL
Glucose [Presence] in Urine by Test strip ++
Bilirubin.total [Mass/volume] in Urine by Test strip 1.2 0 - 1.5 mg/dL
Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine
Ketones [Mass/volume] in Urine by Test strip 12.5 0 - 20 mg/dL
Ketones [Presence] in Urine by Test strip Urine ketone test = ++
Specific gravity of Urine by Test strip 1.0 L 1.005 - 1.03 {nominal}
pH of Urine by Test strip 5.3 4.6 - 7 pH
Protein [Mass/volume] in Urine by Test strip 387.3 H 0 - 145 mg/dL
Protein [Presence] in Urine by Test strip Urine protein test = ++
Nitrite [Presence] in Urine by Test strip Urine nitrite negative
Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative
Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative
Hemoglobin A1c/Hemoglobin.total in Blood 3.2 L 3.8 - 5.7 %

Device Use

Device Date (since)
Home nebulizer (physical object) 29-Jan-2003
Blood glucose meter (physical object) 07-Dec-1971